Breaking

Breaking

news-15102024-020709

Broad Institute Layoffs: Impact on IT and Software Engineering Staff

The Broad Institute of MIT and Harvard, known for its groundbreaking biotech research, recently made the decision to lay off 87 employees. This move comes as the institute undergoes some restructuring within its teams....
news-14102024-200606

Jasper Reports Positive Data for Skin Condition Drug, Aiming to Rival Genentech and Novartis

Jasper Therapeutics, a biotech company focusing on improving stem cell transplants and treating immune-mediated diseases, shared positive results from an initial clinical trial of its experimental drug for a chronic skin condition. The drug,...
news-14102024-140427

Revolutionizing Autoimmune Treatment: The Rise of CAR-T Therapy in Biotech

Biotech investors have been showing a lot of interest in the field of autoimmune diseases this year. While the obesity market is also attracting attention, autoimmune conditions have been at the forefront of drug...
news-14102024-020014

Struggling Gene-Editing Biotech SalioGen Therapeutics Faces Layoffs

SalioGen Therapeutics, a biotech company that secured $135 million in funding to develop a cutting-edge gene-editing technology, is facing a challenging situation as it recently laid off a significant number of employees and adjusted...
news-13102024-194954

Alleged Pfizer Threats and Industry Payments: Pharmalittle News Update

As the week comes to a close, many of us are looking forward to the weekend. Whether it's spending time with family, enjoying the outdoors, or simply relaxing, we all have our own plans....
news-13102024-072210

Expanding Harris’ Medicare at Home Plan to Better Serve Seniors

Imagine a world where your elderly mother could receive quality care at home without bankrupting your family. Now picture that same world, but with a twist: The caregiver isn’t a typical home care worker,...
news-13102024-012027

Readers’ Opinions on Covid, Trump, Rare Diseases, and Institutional Neutrality: A Comprehensive Overview

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.“To encourage robust, good-faith discussion about issues raised...
news-12102024-191825

Kamala Harris Receives Positive Health Report: In Excellent Condition

Vice President Kamala Harris has recently received a positive health report, indicating that she is in excellent health and possesses the physical and mental resilience needed to serve as president. The report was released...
news-12102024-131653

Denali-Sanofi Partnership Faces a Major Setback

Sanofi, a French drugmaker, is in talks to sell a 50% stake in its consumer health business, Opella, for $16 billion to a U.S. private equity firm. Camp4 Therapeutics raised $75 million in an...
news-12102024-071512

FDA Reconsiders Removing Eli Lilly Weight Loss Drug from Shortage List

The Food and Drug Administration, or FDA, announced on Friday that it would be revisiting its decision to remove Eli Lilly's tirzepatide, which is known as Mounjaro for diabetes and Zepbound for obesity, from...
news-12102024-011356

Gender Disparity in Science Nobel Prizes: A Deeper Issue

Since the Nobel Prizes were established in 1901, only 24 women have been recognized in the field of science. This year, the trend continued as all seven laureates in physics, chemistry, and physiology or...
news-11102024-191145

Navigating the Corporate Ladder: Latest Updates and Transitions

Pharmalot Columnist, Senior WriterHave you recently hired a new and exciting employee? Promoted a rising star within your company? Finally filled a challenging position? Don't keep it to yourself - share the news with...

BREAKING NEWS

Top News